-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Kiora Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
- Kiora Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $189K, a 21.4% increase year-over-year.
- Kiora Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $684K, a 177% increase year-over-year.
- Kiora Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was $163K.
- Kiora Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was -$1.39M, a 609% decline from 2021.
- Kiora Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was $272K, a 1323% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)